Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 100 /hr
Hire Dr. Adam E.
Australia
USD 100 /hr
Freelance drug and medical device Regulatory Affairs consultant | Expert in preclinical and clinical trial design
Profile Summary
Subject Matter Expertise
Services
Writing
Medical Writing,
Non-Medical Regulatory Writing,
Technical Writing
Research
Gap Analysis,
Scientific and Technical Research,
Systematic Literature Review
Consulting
Scientific and Technical Consulting,
Regulatory Consulting
Data & AI
Statistical Analysis,
Image Processing,
Image Analysis
Product Development
Formulation,
Stability/Shelf Life Testing,
Product Validation,
Quality Assurance & Control (QA/QC)
Work Experience
Research Officer
Sir Charles Gairdner Hospital
July 2018 - Present 
Research Officer
Perron Institute for Neurological and Translational Science
July 2018 - Present
Education
Doctorate of Philosophy (PhD) (Health Sciences)
University of Notre Dame Australia
January 2015 - August 2018
Bachelor of Biomedical Science (Hons) (Health Sciences)
University of Notre Dame Australia
March 2011 - December 2014
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2018). Assessment of therapeutic window for poly-arginine-18D (R18D) in a P7 rat model of perinatal hypoxic-ischaemic encephalopathy . Journal of Neuroscience Research. 96. (11). p. 1816-1826.
Edwards, A.B., Cross, J.L., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2018). Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat . Molecular Brain. 11. (1).
Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2018). Perinatal hypoxic-ischemic encephalopathy and neuroprotective peptide therapies: A case for cationic arginine-rich peptides (CARPs) . Brain Sciences. 8. (8).
Chiu, L.S., Anderton, R.S., Cross, J.L., Clark, V.W., Chiu, L.S., Anderton, R.S., Cross, J.L., Clark, V.W., Edwards, A.B., Knuckey, N.W., et al.(2017). Assessment of R18, COG1410, and APP96-110 in excitotoxicity and traumatic brain injury . Translational Neuroscience. 8. (1). p. 147-157.
Meloni, B.P., Milani, D., Cross, J.L., Meloni, B.P., Milani, D., Cross, J.L., Clark, V.W., Edwards, A.B., Anderton, R.S., Blacker, D.J., et al.(2017). Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine–Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats . NeuroMolecular Medicine. 19. (2-3). p. 271-285.
Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P., Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2017). Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model . Molecular and Cellular Biochemistry. 426. (1-2). p. 75-85.
Edwards, A.B., Feindel, K.W., Cross, J.L., Anderton, R.S., Clark, V.W., Knuckey, N.W., Meloni, B.P.(2017). Modification to the Rice-Vannucci perinatal hypoxic-ischaemic encephalopathy model in the P7 rat improves the reliability of cerebral infarct development after 48 hours . Journal of Neuroscience Methods. 288. p. 62-71.
Meloni, B.P., Brookes, L.M., Clark, V.W., Cross, J.L., Edwards, A.B., Anderton, R.S., Hopkins, R.M., Hoffmann, K., Knuckey, N.W.(2015). Poly-arginine and arginine-rich peptides are neuroprotective in stroke models . Journal of Cerebral Blood Flow and Metabolism. 35. (6). p. 993-1004.
(2015). Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties . Pharmacology and Therapeutics. 153. p. 36-54.
Ratings and Comments
Total Projects Awarded:
Comments:
